In fact, as thromboembolic disease is a common complication of pancreatic cancer because of the generation of an intrinsic hypercoagulable state39,40, an earlier study suggested that the pharmacological inhibition of platelet-derived TGF-β might inhibit metastasis37,38. The gene discussed is TGFB1; the disease is pancreatic neoplasm.